- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Trastuzumab Injection
Total 10691 results
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Genor Biopharma Co., Ltd.Completed
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
Spanish Breast Cancer Research GroupCompleted
-
University Medical Center GroningenCompleted
-
PfizerCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedMetastatic Breast Cancer | Metastatic Gastric CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-PositiveRecurrent or Metastatic Breast Cancer
-
University Medical Center GroningenAmsterdam UMC, location VUmc; University Medical Center NijmegenActive, not recruitingMetastatic Breast CancerNetherlands
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Afyonkarahisar Health Sciences UniversityCompletedMusculoskeletal Diseases | Shoulder Pain | Rotator Cuff Tendinopathy | Rotator Cuff SyndromeTurkey
-
Jonsson Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Hoffmann-La RocheCompletedBreast NeoplasmsFrance, Spain, Sweden, Denmark, Russian Federation, Canada, Germany, United Kingdom, Italy, Turkey, Poland, Switzerland
-
Genor Biopharma Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Consorzio OncotechRoche Pharma AGRecruiting
-
Jules Bordet InstituteWithdrawnMetastatic HER2-positive Breast Cancer With Brain Metastasis
-
MedSIRHoffmann-La RocheNot yet recruiting
-
Shanghai Miracogen Inc.RecruitingAdvanced Breast Cancer | Metastatic Breast CancerChina
-
Vivozon, Inc.CompletedPost-Operative PainKorea, Republic of
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingBreast Ductal Carcinoma In SituUnited States, Canada, Puerto Rico, Korea, Republic of
-
Tianjin Medical University Cancer Institute and...Not yet recruitingHER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
-
NRG OncologyNational Cancer Institute (NCI)RecruitingRecurrent Salivary Gland Carcinoma | Stage III Major Salivary Gland Cancer AJCC v8 | Stage IV Major Salivary Gland Cancer AJCC v8 | Metastatic Salivary Gland Carcinoma | Unresectable Salivary Gland CarcinomaUnited States
-
Vivozon, Inc.CompletedPost-Operative PainKorea, Republic of
-
Bio-Thera SolutionsActive, not recruiting
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedHIV InfectionsUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
Rehabilitace MUDr. Hasan Mezian s.r.o.UnknownCarpal Tunnel SyndromeCzechia
-
UNICANCERSeagen Inc.RecruitingHER2-positive Metastatic Breast Cancer | Leptomeningeal Disease | Leptomeningeal MetastasisFrance
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Fudan UniversityHoffmann-La RocheUnknown
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Second Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
University of LeipzigCelgene CorporationRecruitingMyelodysplastic Syndromes | AnemiaGermany
-
Vivozon, Inc.CompletedPost-Operative PainKorea, Republic of
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage IIA Breast Cancer AJCC v8 | Prognostic Stage IIB Breast Cancer... and other conditionsUnited States, Puerto Rico
-
Orano Med LLCCompletedStomach Neoplasms | Breast Neoplasms | Pancreatic Neoplasms | Ovarian Neoplasms | Peritoneal NeoplasmsUnited States
-
National Cancer Institute (NCI)Active, not recruitingMale Breast Carcinoma | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Puerto Rico
-
RemeGen Co., Ltd.Completed
-
Samsung Bioepis Co., Ltd.TerminatedBreast NeoplasmsUkraine, Romania, Russian Federation, France, Bulgaria, Czechia, Poland
-
University Medical Center GroningenCompleted
-
Indiana UniversityCompletedPancreatic Cancer | Chronic PancreatitisUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Fudan UniversityCompleted
-
BiogenCompleted
-
RemeGen Co., Ltd.RecruitingAdvanced Melanoma | Melanoma, Stage II | HER2-positiveChina
-
RemeGen Co., Ltd.Active, not recruitingBiliary Tract CancerChina
-
RemeGen Co., Ltd.CompletedGastric Cancer | HER2 Overexpressing Gastric CarcinomaChina
-
RemeGen Co., Ltd.RecruitingGynecological MalignancyChina